Projects per year
Abstract
The kynurenine metabolite is associated with many diseases and disorders, ranging from diabetes and sepsis to more recently COVID-19. Here we report a fluorescence-based assay for the detection of kynurenine in urine using a specific chemosensor, 3-formyl-4-(ethylthio)-7-(diethylamino)-coumarin. The assay produces a linear response at clinically relevant ranges (1–20 μM), with a limit of detection of 0.7 μM. The average standard addition recoveries of kynurenine in synthetic urine samples are near to 100%, and the relative standard deviation values are less than 8%. The established fluorescence assay for quantitative analysis of kynurenine in urine is facile, sensitive and accurate and holds great potential for low-cost and high-throughput analysis of kynurenine in clinical laboratory settings.
Original language | English |
---|---|
Article number | 1931 |
Pages (from-to) | 1931-1936 |
Number of pages | 6 |
Journal | The Analyst |
Volume | 147 |
Issue number | 9 |
Early online date | 30 Mar 2022 |
DOIs | |
Publication status | E-pub ahead of print - 30 Mar 2022 |
Fingerprint
Dive into the research topics of 'Establishing a quantitative fluorescence assay for the rapid detection of kynurenine in urine'. Together they form a unique fingerprint.Projects
- 2 Finished
-
FP7_ERC - GLYCOSURF
Mendes, P. (Principal Investigator)
European Commission, European Commission - Management Costs
1/12/14 → 31/05/21
Project: Research
-
Surface-Based Molecular Imprinting for Glycoprotein Recognition
Fossey, J. (Co-Investigator) & Mendes, P. (Principal Investigator)
Engineering & Physical Science Research Council
30/09/13 → 31/05/19
Project: Research Councils